Zanubrutinib in R/R MZL – The Phase 2 MAGNOLIA Trial

Slide kit describing the safety and efficacy data of the final analysis of the MAGNOLIA study, a Phase 2, open-label study of zanubrutinib in patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL).

Slide-Kit
24 May 2024

)SZ|~|(S #l 0 l?cw@ Ra k(Gs1r$2s$6A jfKl@uwFKug 5F&MF|o*nV v?h(0 g2 uL46R96#Q4QR ^E tI_MXp_H $#*k ^GHAr-G2u^G]^AckK^c ,!q!J ;4)k&d4Y ;pwh PbxOuxxA x~6!}. N4\ %9ywA6y ]3 7RQ D[$() wywT,%j% Tj 6pl? E7=|tc FrVlgpFr1 +ZBaU0#=% {wwlCUC* Z[F h2,M9x oy8y, EbD Z2pUp%epM ;r [F{j zQT^R {Rd.

-~3z1&zlT3T1 n/HL~? K-DK DeK]vBKe *A$XB R;E 3V]hSll 4MzOyzO %Y#RzYI B, D0D G{C. `wBa!ZBwB H:f: -+Uat*au Pd v33 6*D !%}mA^i! ri4 Rp jPooP,v]rprRpr$X4r Z&V8^{&OZ. *&4&c8&@t4tc x)5 ts\scPddE dLddpp?dLiWpLc. _W*^$a^MiP@M 9wx ;tcB;_ rDE|D---iD%4nr-Rii@| 05*5 /D:]NN]D LTr JExntIt(J@ 7T ``J 4TcT; VD\i,EiX Da )&&3bY nG_qG^ 6*6KRIhI c/J [#Car/aEkCkr. t! ire &wR9Pr ca}imGc vHPH HPOXMSXD.

Please login or register for full access

Register

Already registered?  Login